来自MSN2 个月
Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of acquisition, earning more than $7.3 billion in revenue from 2017 to 2022 ...
Healthcare Finance News2 个月
FTC says top three PBMs made $7.3 billion from marked up drug prices
The "Big 3" PBMs also separately generated an estimated $1.4 billion of income from spread pricing, FTC finds. Jeff Lagasse, Editor A complete guide to lease accounting for healthcare organizations ...
来自MSN2 个月
PBMs made more than $7B marking up specialty generics: FTC
The three biggest pharmacy benefit managers made more than $7.3 billion over five years marking ... What they found: The PBMs marked up prices for specialty generic drugs by hundreds and sometimes ...
Alabama Political Reporter3 天
Senate committee approves bill regulating PBMs, protecting local pharmacies
A new Senate bill would prohibit PBMs from negative reimbursements and make other changes to protect independent pharmacies.
pharmaphorum5 天
PBMs under the cosh at House hearing on drug pricing
The tough questioning was fuelled by a report published ahead of the hearing and prepared by Committee staff, which concluded that the actions of the PBMs, which are responsible for negotiating ...